A founding member of the Society for Biomolecular Imaging and Informatics, Johnston has been a member of SBS/now SLAS since 1998, and he chairs the HCS/HCA data and informatics special interest group.
Dudgeon D, Shinde, SN, Hua, Y, Shun, TY, Lazo, JS, Strock, CJ, Giuliano, KA, Taylor, DL, Johnston, PA, and Johnston, PA. Implementation of a 220,000 Compound HCS Campaign to Identify Disruptors of the Interaction between p53 and hDM2, and Characterization of the Confirmed Hits. J Biomol Screen. 2010. 15: 766-782.
Close DA, Wang AX, Kochanek SJ, Shun T, Eiseman JL, Johnston PA. Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) Database. SLAS Discov. 2019 Mar;24(3):242-263.
Kochanek SJ, Close DA, Wang AX, Shun T, Empey PE, Eiseman JL, Johnston PA. Confirmation of Selected Synergistic Cancer Drug Combinations Identified in an HTS Campaign and Exploration of Drug Efflux Transporter Contributions to the Mode of Synergy. SLAS Discov. 2019 Apr 30:653-668.
Kochanek SJ, Close DA, Camarco DP, Johnston PA. Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines. SLAS Discov. 2020 Jan 25:1-21.
SLAS publishes two PubMed:MEDLINE-indexed journals and accepts manuscripts on an ongoing basis from members and non-members. > READ MORE
March 20, 2020